Patients with MAP carry bi‐allelic loss‐of‐function mutations in the MUTYH gene, which in targeted sequencing studies of adenomas was found to manifest as an increase in somatic G:C → T:A mutations at the APC locus 17. The gene discussed is APC; the disease is adenoma.